Menu

Prescribing guidelines

Loading…

Clinical support by body system

Conditions and indicators

Alcohol dependence1
Allergic rhinitis1
Angina pectoris1
Antiplatelets1
Asthma2
Atrial fibrillation1
Cancer : Palliative care1
Depression2
Dysphagia1
Epilepsy3
Heart failure4
Incontinence2
Inflammatory Bowel Disease1
Neuropathic pain1
Obesity and bariatric surgery1
Osteoporosis2
Pain management6
Peptic ulcers1
Rheumatoid arthritis1
Stroke2
Substance dependence1
Transient Ischaemic Attack TIA1
Type 1 Diabetes2
Type 2 Diabetes2

Traffic light

April 2022 - APC Approved list of guideline review date extensions (to 3 years from date approved)

MSK: Bisphosphonates - Drug holidays

Dermatology, MSK and Rheumatology
MSK: Calcium + Vitamin D or VitD choices (APC Approved)

Dermatology, MSK and Rheumatology
MSK: Febuxostat - Gout (APC Approved)

Dermatology, MSK and Rheumatology
MSK: Fracture Prevention and Osteoporosis (APC Approved)

Dermatology, MSK and Rheumatology
MSK: Osteoporosis Management in Primary Care - Summarised Pathway (APC Approved)
MSK: Rubefacients APC Position Statement (APC Approved)

Dermatology, MSK and Rheumatology
MSK: Use of Calcium and Vitamin D Post Fragility Fracture (APC Approved)

Dermatology, MSK and Rheumatology
MSK: Vitamin D guidelines - Adult (APC Approved)

Cancer, Palliative Care, Pain and Older People Dermatology, MSK and Rheumatology Gastroenterology Laboratory investigations and Infections
MSK: Vitamin D Guidelines - Children (APC Approved)

Dermatology, MSK and Rheumatology Paediatrics
Neuro: South Yorkshire Rimegepant (Vydura®) Supporting Information for Acute Treatment of Migraine in Adults (IMOC approved)

Did you find this page helpful?